3/6/2026China Approves Novo's Weekly Insulin–GLP-1 Combination Therapy for Ty...

3/6/2026Abbisko Doses First Patient in Trial of KRAS G12D Inhibitor ABSK141

3/6/2026Lynk's Zemprocitinib Meets Phase III Endpoints in Atopic Dermatitis

3/6/2026Sciwind's Ecnoglutide Approved in China for Obesity

3/5/2026CMS Wins China Trial Approval for INHBE-Targeting Obesity siRNA Drug

3/4/2026CSPC's Emicizumab Injection Receives Clinical Trial Approval in China

3/4/2026Minwei Biotech's siRNA Therapy MWX401 Cleared for Clinical Trials in C...

3/4/2026Eli Lilly Advances New Oral Diabetes Therapy in China

3/3/2026LongBio Pharma's LP‑003 Shows Superior Efficacy Over Xolair in Phase ...

3/3/2026China Approves Five NMEs in February as Innovation Expands Globally

3/2/2026China Approves Jaypirca for Expanded Blood Cancer Indications

3/2/2026RemeGen NDA for RC288 Dual-Target ADC Accepted by NMPA

3/2/2026MediLink Advances HER3 ADC YL202 Into Two Phase III Trials in China

3/2/2026NMPA Approves Rovalicitinib for First-Line Myelofibrosis

3/2/2026Innovent Registers Phase I Study for FIC Dual-Payload Bispecific ADC

3/2/2026Sanofi Secures Two New China Approvals for Dupilumab

2/27/2026CSPC Launches Phase III Program for SYH2053 PCSK9 siRNA in China

2/27/2026Evopoint Biosciences Highlights Igermetostat Data at ASCO GU 2026 in m...

2/26/2026BMS-Partnered Bispecific ADC Achieves Dual Survival Milestones in Chin...

2/26/2026Health Guard's Trial Suspensions Deepen Pressure on China's HPV Vaccin...

2/26/2026Jiuyuan Files for Approval of Wegovy Biosimilar in China

2/26/2026Pfizer Updates Pneumococcal Vaccine Trial in China, Implications for I...

2/25/2026CStone Secures UK Approval for Sugemalimab in Stage III NSCLC

2/25/2026Kelun-Biotech's sac-TMT OS Data Selected as Late-Breaker at ELCC 2026

2/24/2026Biokin's Iza-Bren Achieves Second Phase III Survival Success in China ...

2/24/2026Huadong Launches Head-to-Head Phase III Trial for Dual GLP-1/GIP Agoni...

2/24/2026GenSci Advances PD-1 Agonist Into Phase 2b for Rheumatoid Arthritis

2/24/2026Ascentage Registers U.S. Phase 1 Trial for BTK PROTAC APG-3288

2/24/2026United Labs and Novo Nordisk Post Strong Phase 2 Data for UBT251 Tripl...

2/20/2026CSPC's Long-Acting SYH2082 Clears FDA to Begin Clinical Trials

Page:2/22 Total number of articles:645: [First][<<] [1] [2] [3] [4] [5] [>>] [End]